{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T20:05:23Z","timestamp":1708632323493},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDS"],"published-print":{"date-parts":[[2018,9,17]]},"DOI":"10.2174\/1574886313666180608080355","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:55:46Z","timestamp":1533117346000},"page":"214-216","source":"Crossref","is-referenced-by-count":7,"title":["Denosumab-induced Normocalcemic Hyperparathyroidism in a Woman with Postmenopausal Osteoporosis and Normal Renal Function"],"prefix":"10.2174","volume":"13","author":[{"given":"Elias E.","family":"Mazokopakis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Naval Hospital of Crete, Chania, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/162896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T07:09:36Z","timestamp":1537254576000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/162896\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886313666180608080355","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,17]]}}}